[Federal Register Volume 75, Number 8 (Wednesday, January 13, 2010)]
[Notices]
[Page 1814]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-508]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 28, 2009 and published in the Federal 
Register on September 8, 2009, (74 FR 46232), Noramco Inc., Division of 
Ortho McNeil, Inc., 500 Swedes Landing Road, Wilmington, Delaware 
19801-4417, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Noroxymorphone (9668), a basic class of controlled substance listed in 
schedule II.
    The company plans to bulk manufacture the listed controlled 
substance as a reference standard for distribution to its customers 
which are analytical laboratories.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Noramco Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Noramco Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: January 6, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-508 Filed 1-12-10; 8:45 am]
BILLING CODE 4410-09-P